The Contribution of Genetic and Epigenetic Mechanisms to Gene Silencing in Oligodendrogliomas

Cancer Research

Volumn 63, Issue 22, 2003, Pages 7600-7605

  Hong, Chibo ^a,c   Bollen, Andrew W ^b,c   Costello, Joseph F ^a,b,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CELL LINE; CONTROLLED STUDY; CPG ISLAND; DEMETHYLATION; GEMIN7 GENE; GENE; GENE DELETION; GENE EXPRESSION; GENE IDENTIFICATION; GENE LOCATION; GENE SILENCING; GENE TARGETING; GLIOMA CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; METHYLATION; MOLECULAR GENETICS; MOLECULAR MECHANICS; OLIGODENDROGLIOMA; PREVALENCE; PRIORITY JOURNAL; UPREGULATION; ZINC FINGER MOTIF; ZNF342 GENE;

BRAIN NEOPLASMS; CPG ISLANDS; DNA METHYLATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE SILENCING; HUMANS; NUCLEIC ACID HYBRIDIZATION; OLIGODENDROGLIOMA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS, DNA;

EID: 0344844484     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Jones, P. A., and Baylin, S. B. The fundamental role of epigenetic events in cancer. Nat. Rev. Genet., 3: 415-428, 2002.
2. Costello, J. F., and Plass, C. Methylation matters. J. Med. Genet., 38: 285-303, 2001.
3. Lander, E. S., Linton, L. M., Birren, B., Nusbaum, C., Zody, M. C., Baldwin, J., Devon, K., Dewar, K., Doyle, M., FitzHugh, W., et al. Initial sequencing and analysis of the human genome. Nature (Lond.) 409: 860-921, 2001.
4. Hatada, I., Hayashizaki, Y., Hirotsune, S., Komatsubara, H., and Mukai, T. A genomic scanning method for higher organisms using restriction sites as landmarks. Proc. Natl. Acad. Sci. USA, 88: 9523-9527, 1991.
5. Zardo, G., Tiirikainen, M. I., Hong, C., Misra, A., Feuerstein, B. G., Volik, S., Collins, C. C., Lamborn, K. R., Bollen, A., Pinkel, D., et al. Integrated genomic and epigenomic analyses pinpoint biallelic gene inactivation in tumors. Nat. Genet., 32: 453-458, 2002.
6. Pinkel, D., Seagraves, R., Sudar, D., Clark, S., Poole, I., Kowbel, D., Collins, C., Kuo, W. L., Chen, C., Zhai, Y., et al. High resolution analysis of DNA copy number variation using comparative genomic hybridization to microarrays. Nat. Genet., 20: 207-211, 1998.
7. Paleologos, N. A., and Cairncross, J. G. Treatment of oligodendroglioma: an update. Neuro-oncol, 1: 61-68, 1999.
8. Cairncros, J. G., Ueki, K., Zlatescu, M. C., Lisle, D. K., Finkelstein, D. M., Hammond, R. R., Silver, J. S., Stark, P. C., Macdonald, D. R., Ina, Y., et al. Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas. J. Natl. Cancer Inst., 90: 1473-1479, 1998.
9. Smith, J. S., Perry, A., Borell, T. J., Lee, H. K., O'Fallon, J., Hosek, S. M., Kimmel, D., Yates, A., Burger, P. C., Scheithauer, B. W., et al. Alterations of chromosome arms 1p and 19q as predictors of survival in oligodendrogliomas, astrocytomas, and mixed oligoastrocytomas. Journal of Clinical Oncology. 18: 636-645, 2000.
10. Jenkins, R. B., Curran, W., Scott, C. B., and Cairncross, G. Pilot evaluation of 1p and 19q deletions in anaplastic oligodendrogliomas collected by a national cooperative cancer treatment group. Am. J. Clin. Oncol., 24: 506-508, 2001.
11. Alonso, M. E., Bello, M. J., Gonzalez-Gomez, P., Arjona, D., Lomas, J., de Campos, J. M., Isla, A., Sarasa, J. L., and Rey, J. A. Aberrant promoter methylation of multiple genes in oligodendrogliomas and ependymomas. Cancer Genet. Cytogenet., 144: 134-142, 2003.
12. Dong, S. M., Pang, J. C. S., Hu, J., Zhou, L. F., and Ng, H. K. Transcriptional inactivation of TP73 expression in oligodendroglial tumors, Int. J. Cancer, 98: 370-375, 2002.
13. Wolter, M., Reifenberger, J., Blaschke, B., Ichimura, K., Schmidt, E. E., Collins, V. P., and Reifenberger, G. Oligodendroglial tumors frequently demonstrate hypermethylation of the CDKN2A (MTS1, p16(INK4a)), p14(ARF), and CDKN2B (MTS2, p15(INK4b)) tumor suppressor genes. J. Neuropathol. Exp. Neurol., 60: 1170-1180, 2001.
14. Watanabe, T., Nakamura, M., Yonekawa, Y., Kleihues, P., and Ohgaki, H. Promoter hypermethylation and homozygous deletion of the pl4(ARF) and p16(INK4a) genes in oligodendrogliomas. Acta Neuropathol., 101: 185-189, 2001.
15. Uhlmann, K., Rohde, K., Zeller, C., Szymas, J., Vogel, S., Marczinek, K., Thiel, G., Nurnberg, P., and Laird, P. W. Distinct methylation profiles of glioma subtypes. Int. J. Cancer, 106: 52-59, 2003.
16. Jain, A. J., Tokuyasu, T. A., Snijders, A. M., Segraves, R., Albertson, D. G., and Pinkel, D. Fully automatic quantification of microarray image data. Genome Res., 12: 325-332, 2002.
17. Li, H., Myeroff, L., Smiraglia, D., Romero, M. F., Pretlow, T. P., Kasturi, L., Lutterbaugh, J., Rerko, R. M., Casey, G., Issa, J. P., et al. SLC5A8, a sodium transporter, is a tumor suppressor gene silenced by methylation in human colon aberrant crypt foci and cancers. Proc. Natl. Acad. Sci. USA, 100: 8412-8417, 2003.
18. Bello, M. J., Leone, P. E., Nebreda, P., de Campos, J. M., Kusak, M. E., Vaquero, J., Sarasa, J. L., Garcia-Miguel, P., Queizan, A., Hernandez-Moneo, J. L., et al. Allelic status of chromosome I in neoplasms of the nervous system. Cancer Genet. Cytogenet., 83: 160-164. 1995.
19. Smith, J. S., Alderete, B., Minn, Y., Borell, T. J., Perry, A., Mohapatra, G., Hosek, S. M., Kimmel, D., O'Fallon, J., Yates, A., et al. Localization of common deletion regions on 1p and 19q in human gliomas and their association with histological subtype. Oncogene, 18: 4144-4152, 1999.
20. Iuchi, T., Namba, H., Iwadate, Y., Shishikura, T., Kageyama, H., Nakamura, Y., Ohira, M., Yamaura, A., Osato, K., Sakiyama, S., et al. Identification of the small interstitial deletion at chromosome band 1p34-p35 and its association with poor outcome in oligodendroglial tumors. Genes Chromosomes Cancer, 35: 170-175, 2002.
21. Reifenberger, J., Reifenberger, G., Liu, L., James, C. D., Wechsler, W., and Collins, V. P. Molecular genetic analysis of oligodendroglial tumors shows preferential allelic deletions on 19q and 1p. Am. J. Pathol., 145: 1175-1190, 1994.
22. Smith, J. S., Tachibana, I., Lee, H. K., Qian, J., Pohl, U., Mohrenweiser, H. W., Borell, T. J., Hosek, S. M., Soderberg, C. L., von Deimling, A., et al. Mapping of the chromosome 19q-arm glioma tumor suppressor gene using fluorescence in situ hybridization and novel microsatellite markers. Genes Chromosomes Cancer, 29: 16-25, 2000.
23. Wolf, R. M., Draghi, N., Liang, X., Dai, C., Uhrbom, L., Eklof, C., Westermark, B., Holland, E. C., and Resh, M. D. p190RhoGAP can act to inhibit PDGF-induced gliomas in mice: a putative tumor suppressor encoded on human chromosome 19q13.3. Genes Dev., 17: 476-487, 2003.
24. Yoshikawa, H., de la Monte, S., Nagai, H., Wands, J. R., Matsubara, K., and Fujiyama, A. Chromosomal assignment of human genomic NotI restriction fragments in a two-dimensional electrophoresis profile. Genomics, 31: 28-35, 1996.
25. Costello, J. F., Fruhwald, M. C., Smiraglia, D. J., Rush, L. J., Robertson, G. P., Gao, X., Wright, F. A., Feramisco, J. D., Peltomaki, P. Lang, J. C., et al. Aberrant CpG-island methylation has non-random and tumour-type-specific patterns. Nat. Genet., 24: 132-138, 2000.
26. Smiraglia, D. J., Frühwaid, M. C., Costello, J. F., McCormick, S. P., Peltomaki, P., O'Dorisio, M. S., Cavenee, W. K., and Plass, C. A new tool for the rapid cloning of amplified and hypermethylated human DNA sequences from restriction landmark genomic scanning gels. Genomics, 58: 254-262, 1999.